Department of Health and Human Services April 11, 2005 – Federal Register Recent Federal Regulation Documents
Results 1 - 21 of 21
Galveston National Laboratory Record of Decision
The Department of Health and Human Services, the National Institutes of Health (NIH), has decided, after completion of a Final Environmental Impact Statement (EIS) and a thorough consideration of the public comments on the Draft EIS to implement the Proposed Action, which is identified as the Preferred Alternative in the Final EIS. This action is to partially fund the construction of a state-of-the-art National Biocontainment Laboratory (NBL), which will be known as the Galveston National Laboratory (GNL), on the University of Texas Medical Branch (UTMB) Campus in Galveston, Texas.
Prospective Grant of Exclusive License: Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors as Applied to the Treatment of Human Cancer and Tumors
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive license to practice the invention embodied in Patent Applications U.S. 60/340,772, filed on 12/12/2001, U.S. 60/342,582, filed on 12/19/2001, PCT/US2002/036829, filed on 11/14/2002, and corresponding EP, CA, AU, and JP filings, as well as U.S. 10/498,416, filed on 06/10/2004; entitled ``Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation'', all by Michail V. Sitkovsky and Akio Ohta, to Adenosine Therapeutics, LLC, having a place of business in Charlottesville, VA. The patent rights in this invention have been assigned to the United States of America.
Best Practices for the Licensing of Genomic Inventions: Final Notice
On November 19, 2004 the National Institutes of Health (NIH) published for public comment in the Federal Register proposed Best Practices for the Licensing of Genomic Inventions [69 FR 67747]. These Best Practices are recommendations to the intramural Public Health Service (PHS) technology transfer community as well as to PHS funding recipients. Comments on the proposed Best Practices were requested with a deadline of January 18, 2005. This Notice presents the NIH's final Best Practices for the Licensing of Genomic Inventions together with NIH's response to the public comments received.
Meeting of the Advisory Committee on Minority Health
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the Advisory Committee on Minority Health (ACMH) will hold a meeting. This meeting is open to the public.
Notice of Meeting of the Advisory Committee on Organ Transplantation
Pursuant to Pub. L. 92-463, the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the eighth meeting of the Advisory Committee on Organ Transplantation (ACOT), Department of Health and Human Services (HHS). The meeting will be held from approximately 9 a.m. to 5:30 p.m. on May 9, 2005, and from 9 a.m. to 3 p.m. on May 10, 2005, at the Rockville DoubleTree Hotel, 1750 Rockville Pike, Rockville, Maryland 20852. The meeting will be open to the public; however, seating is limited and pre-registration is encouraged (see below).
Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
